Pacific Biosciences of California, Inc. PACB
NASDAQ · United States · Health Technology
$2.45-0.06 (-2.59%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | -0.14 | -0.14 | 0.0% | $39.01M | -2.3% | -18.8%$1.44→$1.17 |
| Q1 2026 | 2026-05-07 | -0.12 | -0.13 | +7.7% | — | — | -17.5%$1.71→$1.41 |
| Q4 2025 | 2026-02-12 | -0.12 | -0.13 | +7.7% | — | — | -7.1%$1.84→$1.71 |
| Q3 2025 | 2025-11-05 | -0.12 | -0.14 | +14.3% | — | — | -11.0%$2.00→$1.78 |
| Q2 2025 | 2025-08-07 | -0.13 | -0.17 | +23.5% | — | — | — |
| Q1 2025 | 2025-05-08 | -0.15 | -0.19 | +21.1% | — | — | — |
| Q4 2024 | 2025-02-13 | -0.20 | -0.17 | -17.6% | — | — | — |
| Q3 2024 | 2024-11-07 | -0.17 | -0.21 | +19.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.